News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,864 Results
Type
Article (13648)
Company Profile (108)
Press Release (249108)
Section
Business (87976)
Career Advice (464)
Deals (15335)
Drug Delivery (64)
Drug Development (36555)
Employer Resources (49)
FDA (6271)
Job Trends (6189)
News (150092)
Policy (14016)
Tag
Academia (435)
Alliances (23173)
Alzheimer's disease (371)
Approvals (6280)
Artificial intelligence (74)
Bankruptcy (144)
Best Places to Work (4357)
Breast cancer (64)
Cancer (451)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (62)
Clinical research (30635)
Collaboration (239)
Compensation (97)
COVID-19 (752)
C-suite (77)
Data (451)
Diabetes (64)
Diagnostics (1250)
Drug discovery (45)
Drug pricing (59)
Earnings (31638)
Events (37014)
Executive appointments (269)
FDA (6539)
Funding (155)
Gene therapy (72)
GLP-1 (314)
Government (1273)
Healthcare (3542)
Infectious disease (774)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5849)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3417)
Lung cancer (64)
Manufacturing (115)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9589)
Metabolic disorders (199)
Neuroscience (498)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (553)
Obesity (119)
Opinion (113)
Patents (70)
People (28653)
Pharmaceutical (67)
Phase I (7979)
Phase II (12952)
Phase III (11632)
Pipeline (232)
Policy (47)
Postmarket research (1401)
Preclinical (3181)
Radiopharmaceuticals (116)
Rare diseases (119)
Real estate (2631)
Regulatory (9934)
Research institute (563)
Resumes & cover letters (55)
Southern California (539)
Startups (1625)
United States (5380)
Vaccines (121)
Weight loss (86)
Date
Today (64)
Last 7 days (179)
Last 30 days (749)
Last 365 days (12369)
2025 (714)
2024 (12508)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19938)
Australia (2577)
California (1296)
Canada (723)
China (170)
Colorado (53)
Connecticut (54)
Europe (39025)
Florida (217)
Illinois (146)
Indiana (104)
Japan (59)
Kansas (53)
Maryland (189)
Massachusetts (1115)
Minnesota (71)
New Jersey (536)
New York (359)
North Carolina (320)
Northern California (553)
Pennsylvania (337)
South America (500)
Southern California (539)
Texas (169)
Virginia (50)
Washington State (85)
262,864 Results for "cardurion pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
January 8, 2025
·
3 min read
Business
Cardurion Raises $260M to Advance Cardiovascular Assets
Backed by Bain Capital, Cardurion Pharmaceuticals will use the Series B funds to advance two assets for heart failure and other cardiovascular conditions.
July 16, 2024
·
1 min read
·
Tyler Patchen
Press Releases
Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors
September 27, 2024
·
3 min read
Press Releases
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company
September 30, 2024
·
2 min read
Drug Development
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
Cardurion Pharmaceuticals, Inc. announced the presentation of positive clinical data from CARDINAL‑HF, the first Phase 2 proof-of-concept clinical trial of a phosphodiesterase-9 inhibitor in patients with heart failure.
May 11, 2024
·
8 min read
Genetown
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference.
January 5, 2024
·
1 min read
Business
Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair
Cardurion Pharmaceuticals, Inc. today announced the appointment of Emma Reeve as an independent board director and audit chair.
October 4, 2023
·
3 min read
Genetown
Cardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program at the American Heart Association’s Scientific Sessions 2023
Cardurion Pharmaceuticals, Inc. today announced that the Company will present preclinical data on its Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) inhibitor program at the American Heart Association’s (AHA) Scientific Sessions 2023.
November 7, 2023
·
3 min read
Business
Cardurion Pharmaceuticals Further Bolsters Leadership Team with Appointment of Stephen Migausky as General Counsel
Cardurion Pharmaceuticals, Inc. today announced the appointment of Stephen Migausky as Senior Vice President and General Counsel.
April 19, 2023
·
2 min read
Business
Cardurion Pharmaceuticals Strengthens Leadership Team with Appointment of Elizabeth Radcliffe as Chief Financial Officer
Cardurion Pharmaceuticals Strengthens Leadership Team with Appointment of Elizabeth Radcliffe as Chief Financial Officer.
January 19, 2023
·
3 min read
1 of 26,287
Next
